Evaluating the potential of stabilised betacyanins from fermented red dragon fruit (Hylocereus polyrhizus) drink: sustainable colouration and antioxidant enhancement of stirred yog... by Lim, Teck Wei, Lim, Renee Lay Hong, Pui, Liew Phing, Tan, Chin Ping

“…This study aimed to evaluate the potential of a functional fruit drink, Improved-FRDFD-dH2O [contained betacyanins of fermented red dragon fruit drink stabilised by 0.4 % xanthan gum and 0.5 % carboxymethyl cellulose hydrocolloid mixture solution and 0.2 % citric acid] to serve as a sustainable and stable functional liquid colourant in yoghurt. …”
Get full text

Investigating viral glycosylation pathways for drug and vaccine development by Brun, J

“…</p> <p>The COVID-19 pandemic highlighted again the lack of broad-spectrum antivirals available to patients before thorough investigation of an emergent virus, such as its genome or target host receptor. Chapter 5 discusses the establishment of a medium-throughput drug screening platform against SARS-CoV-2. …”

18F-labelling of new chemotypes for drug discovery by Khotavivattana, T

“…<b>Chapter 2</b> describes a novel silver-mediated ¹⁸F-labelling of Ar-SCF3, Ar OCF3 and Ar-OCF2H, including [¹⁸F]Riluzole, the ¹⁸F labelled version of a drug for treatment of amyotrophic lateral sclerosis (ALS). …”

Mycobacterium tuberculosis drug resistance detection by pyrosequencing method by Goh, Mei Ling

“…The conventional way of detecting Mycobacterium tuberculosis and its resistance is by culture followed by phenotypic drug susceptibility testing. This laborious process usually takes 4 to 12 weeks due to the slow growing nature of the organism. …”
Get full text

Dengue Virus Non-Structural Protein 5 by El Sahili, Abbas, Lescar, Julien

“…This review focuses on recent progress in characterizing the structure and functions of NS5, a protein responsible for the replication and capping of viral RNA that represents a promising drug target.…”
Get full text
Get full text

Development of biomimetic 3D cancer platform for drug testing by Ker, Sia Fong

Get full text

Can we please have some honesty about drugs by Saad ul Hassan Hashmi

“…Finally, in section four, I will discuss contemporary research on drugs. In section five, I consider more objections to the arguments I have made and draw a final conclusion: that policy should be framed based on evidence.…”
Get full text

Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial by Uhrenholt, L, Sørensen, MER, Lauridsen, KB, Duch, K, Dreyer, L, Christensen, R, Hauge, E-M, Loft, AG, Rasch, MNB, Horn, HC, Taylor, PC, Nielsen, KR, Kristensen, S

“…Between baseline and month 18, a significant shift in TNFi drug-levels were observed in the tapering group resulting in fewer patients with high drug-levels (change: − 14% [95% CI − 27 to − 1%]) and more with low drug-levels (change: 18% [95% CI 5–31%]). …”

Toxicity, permeability and drug-metabolizing enzyme activities of curcumin analogues by Yakubu, Ndatsu

“…To ascertain the toxicity,permeability and drug-metabolizing enzyme activities of BDMC33 and MS65, their in vitro toxicity test at (0-400 μM) on Caco-2 cells using MTT assay, the in vivo toxicity test on zebrafish embryos and larvae at (0-50 μM), and acute toxicity effects (0-30 μM) on adult male zebrafish were investigated for 5 hr, 5 days, and 48 hr of exposure, respectively. …”
Get full text

Liposomal carrier systems for encapsulation of drugs using bicellar mixtures by Lee, Bao Jun

“…This research aims to evaluate the physicochemical properties of bicelles, such as particle size, distribution, and encapsulation efficiency of drugs. The bicelles will be fabricated using the LUCA cycles (freeze-thaw-vortex cycles) by varying the q-ratio (0, 2, 5, 8, 10, and 20) and total lipid concentration (2mM, 5mM and 10mM). …”
Get full text

Silk Fibroin-Based Coatings for Pancreatin-Dependent Drug Delivery by Navamajiti, Natsuda, Gardner, Apolonia, Cao, Ruonan, Sugimoto, Yutaro, Yang, Jee Won, Lopes, Aaron, Phan, Nhi V., Collins, Joy, Hua, Tiffany, Damrongsakkul, Siriporn, Kanokpanont, Sorada, Steiger, Christoph, Reker, Daniel, Langer, Robert, Traverso, Giovanni

Get full text

Dynamic drug combination methods for suppressing bacterial antibiotics resistance adaptation by Bhone, Myint Kyaw

“…It is resistant to many drugs and the glycopeptide vancomycin is the only available antibiotic that is active against MRSA infections. …”
Get full text

Novel drug-eluting stent to reduce fibrosis-induced ureteral stricture by Fong, Timothy Ren Zhong

“…A solution of poly(L-lactide-co-caprolactone) and MMC was spray coated on 2cm long polyurethane stents, with varied drug loading (2.5wt%, 5wt%, 7.5wt%). The stents were then immersed in four different Phosphate Buffer Saline mediums (pH 6, 7, 7.4, 8.5) for drug release over 28 days. …”
Get full text

Pathways to prison: economic, personal and relational motivations for drug offending in Indonesia by Hoyle, C, Jabbar, P

Recent advances in the development of liquid crystalline nanoparticles as drug delivery systems by Leu, Jassica S. L., Teoh, Jasy J. X., Ling, Angel L. Q., Chong, Joey, Loo, Yan Shan, Mat Azmi, Intan Diana, Zahid, Noor Idayu, Bose, Rajendran J. C., Madheswaran, Thiagarajan

Get full text

Green amorphous nanoplex as a new supersaturating drug delivery system by Cheow, Wean Sin, Hadinoto, Kunn

“…The solubility of curcumin as the least-soluble drug is magnified 9-fold upon its transformation to the nanoplex, and the supersaturated condition is maintained for 5 h.…”
Get full text
Get full text

Ultrasound‐Responsive Aqueous Two‐Phase Microcapsules for On‐Demand Drug Release by Field, Rachel D, Jakus, Margaret A, Chen, Xiaoyu, Human, Kelia, Zhao, Xuanhe, Chitnis, Parag V, Sia, Samuel K

Get full text

Layer-by-layer assembled micro and nano carriers for drug delivery applications by Mutukumaraswamy Shaillender

“…In nano- or microparticulate drug delivery, both control of the drug release and interaction of the particles with the cellular environment are critical attributes. …”
Get full text

Controlled-release nanoencapsulating microcapsules to combat inflammatory diseases by Baek, Jong-Suep, Yeo, Eng Wan, Lee, Yin Hao, Tan, Nguan Soon, Loo, Say Chye Joachim

Get full text
Get full text

Exploring drug consumption rooms as ‘inclusion health interventions’: policy implications for Europe by Scher, BD, Chrisinger, BW, Humphreys, DK, Shorter, GW